dr. martens plc - DRMTY

DRMTY

Close Chg Chg %
2.04 -0.14 -6.86%

Pre-Market

1.90

-0.14 (6.86%)

Volume: 1.50K

Last Updated:

Jun 16, 2025, 12:28 PM EDT

Company Overview: dr. martens plc - DRMTY

DRMTY Key Data

Open

$1.90

Day Range

1.90 - 1.90

52 Week Range

0.78 - 2.04

Market Cap

$1.02B

Shares Outstanding

482.25M

Public Float

N/A

Beta

0.92

Rev. Per Employee

N/A

P/E Ratio

177.39

EPS

N/A

Yield

189.50%

Dividend

$0.02

EX-DIVIDEND DATE

Mar 7, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

93.30

 

DRMTY Performance

No Data Available

DRMTY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Dr. Martens Plc - DRMTY

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
1.24B 1.20B 1.10B 1.00B
Sales Growth
+22.90% -2.97% -8.45% -8.82%
Cost of Goods Sold (COGS) incl D&A
500.17M 525.14M 470.13M 444.70M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
50.13M 65.22M 90.83M 92.74M
Depreciation
43.71M 55.11M 83.55M 84.96M
Amortization of Intangibles
6.42M 10.11M 7.29M 7.78M
COGS Growth
+13.86% +4.99% -10.48% -5.41%
Gross Income
740.43M 678.57M 631.82M 560.02M
Gross Income Growth
+29.87% -8.35% -6.89% -11.36%
Gross Profit Margin
+59.68% +56.37% +57.34% +55.74%
2022 2023 2024 2025 5-year trend
SG&A Expense
422.59M 448.97M 473.02M 482.71M
Research & Development
- - - -
-
Other SG&A
422.59M 448.97M 473.02M 482.71M
SGA Growth
+35.57% +6.24% +5.36% +2.05%
Other Operating Expense
- - - -
-
Unusual Expense
- 273.17K 4.69M 26.28M
EBIT after Unusual Expense
317.56M 224.91M 158.80M 51.03M
Non Operating Income/Expense
(4.37M) (10.59M) (1.51M) 765.40K
Non-Operating Interest Income
- 2.29M 3.77M 4.85M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
20.49M 22.50M 40.45M 40.57M
Interest Expense Growth
-62.29% +9.84% +79.78% +0.28%
Gross Interest Expense
20.49M 22.50M 40.45M 40.57M
Interest Capitalized
- - - -
-
Pretax Income
292.70M 191.81M 116.84M 11.23M
Pretax Income Growth
+216.14% -34.47% -39.09% -90.39%
Pretax Margin
+23.59% +15.94% +10.60% +1.12%
Income Tax
45.21M 36.70M 29.90M 5.49M
Income Tax - Current - Domestic
42.61M 31.77M 20.86M 2.04M
Income Tax - Current - Foreign
5.87M 5.17M 8.04M 4.85M
Income Tax - Deferred - Domestic
(3.28M) (240.67K) 1.01M (1.40M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
247.49M 155.11M 86.94M 5.74M
Minority Interest Expense
- - - -
-
Net Income
247.49M 155.11M 86.94M 5.74M
Net Income Growth
+430.88% -37.33% -43.95% -93.40%
Net Margin Growth
+19.95% +12.89% +7.89% +0.57%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
247.49M 155.11M 86.94M 5.74M
Preferred Dividends
- - - -
-
Net Income Available to Common
247.49M 155.11M 86.94M 5.74M
EPS (Basic)
0.4949 0.3101 0.1768 0.0119
EPS (Basic) Growth
+431.01% -37.34% -42.99% -93.27%
Basic Shares Outstanding
500.05M 500.25M 491.75M 481.15M
EPS (Diluted)
0.4936 0.3099 0.1764 0.0118
EPS (Diluted) Growth
+429.61% -37.22% -43.08% -93.31%
Diluted Shares Outstanding
501.45M 500.60M 492.80M 487.05M
EBITDA
367.96M 294.82M 249.64M 170.05M
EBITDA Growth
+21.56% -19.88% -15.33% -31.88%
EBITDA Margin
+29.66% +24.49% +22.65% +16.92%

Dr. Martens Plc in the News